Lucid Diagnostics Inc.

NASDAQ:LUCD

Medical - Devices

Healthcare
$0.41 +3.80%

+$0.04 today

Market cap
$79.38M
Beta
1.08
P/E (TTM)
-2.3
EPS (TTM)
-$0.44
52W Low $0.90High $1.63

Volume 2.70M

Average 0.84M

LUCD Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Lucid Diagnostics Inc.NASDAQ: LUCD

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows, but more slowly than its trailing trend

Q1 FY2026 weighted avg shares of 101.95M shares rose 48.2% year over year, behind the +82.6% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at +41.3% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +48.2% toward the trailing-twelve-month pace of +82.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
101.95M+0.0% QoQ
Last fiscal yearDec 2025
101.95M+101.8% YoY
LTMMar 2026
102.76M+82.6% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+48.2%——
1 year+101.8%——
3-year CAGR+41.3%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
101.95M USD
Year-over-year change
+101.8%
4-year CAGR
+29.7%

Weighted Avg Shares vs competitors

How LUCD compares with its peers on the latest reported figures

  • LUCD's LTM Mar 2026 weighted avg shares of 102.76M shares is the 3rd highest of the 10 companies compared; the peer median is 41.45M shares.
  • Its year-over-year change of +82.6% is the 4th highest of 10, against a peer median of +15.9%.
  • Over three fiscal years its annual growth of +41.3% compares with a peer median of +6.9%.
LUCD Competitors Peer median
Weighted Avg Shares for LUCD and competitors
Company Period LTM YoY 3-year CAGR
IRDOpus Genetics, Inc.LTM Mar 2026406.29M +1283.9%+214.9%
OWLTOwlet, Inc.LTM Mar 2026149.39M +1085.6%+313.6%
LUCDLucid Diagnostics Inc.LTM Mar 2026102.76M +82.6%+41.3%
SEERSeer, Inc.LTM Mar 202656.96M -7.5%-2.7%
RPIDRapid Micro Biosystems, Inc.LTM Mar 202644.81M +2.4%+1.7%
APYXApyx Medical CorporationLTM Mar 202641.45M +15.9%+6.9%
STSSSkyAI, Inc.LTM Mar 202630.8M +191004.4%+2642.4%
AVRAnteris Technologies Global Corp.LTM Mar 202623.58M -20.8%-13.1%
RCELAVITA Medical, Inc.LTM Mar 202621.36M -17.9%+3.7%
SCLXScilex Holding CompanyLTM Mar 202610.28M +60.8%+42.2%
Peer median (excluding LUCD) 41.45M+15.9%+6.9%

Competitors are the stored peer set for LUCD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue500K377K2.43M4.35M4.71M
Cost of Revenue585K3.61M8.48M8.27M7.54M
Gross Profit(85K)(3.24M)(6.05M)(3.92M)(2.84M)
Gross Margin-17.0%-858.6%-249.2%-90.2%-60.3%
Research & Development9.3M11.47M7.25M5.99M5.68B
Selling, General & Admin18.04M39.82M35.66M36.62B41.58B
Operating Expenses27.33M52.93M42.43M42.13M46.8M
Depreciation & Amortization4K1.94M2.5M1.17M872K
EBITDA(27.42M)(54.23M)(49.75M)(44.34M)(57.12M)
EBITDA Margin-5483.0%-14383.8%-2049.1%-1020.2%-1213.7%
Operating Income(27.42M)(56.17M)(48.48M)(46.05M)(49.64M)
Operating Margin-5483.8%-14899.5%-1996.8%-1059.6%-1054.8%
Interest Income088K424K322K386K
Interest Expense659K8K416K26K22K
Other Income / Expenses(659K)0(4.18M)523K(8.37M)
Income Before Tax(28.08M)(56.17M)(52.67M)(45.53M)(58.01M)
Pre-Tax Margin-5615.6%-14899.5%-2169.1%-1047.6%-1232.7%
Income Tax Expense00000
Net Income(28.08M)(56.17M)(52.67M)(45.53M)(58.01M)
Net Margin-5615.6%-14899.5%-2169.1%-1047.6%-1232.7%
EPS (Basic)(0.78)(1.55)(1.26)(1.05)(0.69)
EPS (Diluted)(0.78)(1.55)(1.26)(1.05)(0.69)
Weighted Avg Shares36.06M36.17M41.76M50.52M101.95M
Weighted Avg Shares (Diluted)36.06M36.17M41.76M50.52M101.95M

Lucid Diagnostics Inc.

NASDAQ:LUCD

Intrinsic Alpha fair value

Locked

Current Price

$0.41

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.